RecruitingNCT06501469
Biomarkers in Parkinsonian Syndromes
Studying Atypical progressive supranuclear palsy syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Non-profit organization for scientific research in Parkinson's disease and related disorders
- Principal Investigator
- Maria Stamelou, Prof DrHYGEIA Hospital
- Enrollment
- 200 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2030
Study locations (1)
- HYGEIA Hospital, Parkinson's disease and Movement Disorders Department, Athens, Greece
Collaborators
Biomedical Research Foundation, Academy of Athens
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06501469 on ClinicalTrials.govOther trials for Atypical progressive supranuclear palsy syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06162013The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical ParkinsonismHaukeland University Hospital
- ACTIVE NOT RECRUITINGNANCT05792332Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGNCT06490926NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian SyndromeFujian Medical University Union Hospital
- RECRUITINGNCT06645626Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian SyndromesUniversity Hospital Southampton NHS Foundation Trust
- RECRUITINGNANCT03174938The Swedish BioFINDER 2 StudySkane University Hospital
See all trials for Atypical progressive supranuclear palsy syndrome →